DeLuca Teresa
SEC Form 4 insider trading activity
DeLuca Teresa has filed 6 SEC Form 4 filings (6 transaction rows) across 2 companies, including SGRY, LFST, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.
On the most recent filing, DeLuca Teresa is listed as Director at Surgery Partners, Inc. Inside the rolling window, DeLuca Teresa reported 1 open-market purchase totaling $305K in SGRY and 2 open-market sales totaling $345K in LFST. The largest disclosed transaction in the window is a purchase of 21,250 SGRY shares on Aug 18, 2026, worth $305K.
Companies traded
Other insiders at SGRY
Insider Buying
$305K
reported purchases (SEC code P)
Insider Selling
$345K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has DeLuca Teresa made?
DeLuca Teresa has filed 6 SEC Form 4 filings (6 transaction rows) across 2 companies, including SGRY, LFST since 2026.
Which companies does DeLuca Teresa trade?
DeLuca Teresa has filed SEC Form 4 disclosures for 2 companies, including SGRY, LFST.
When was DeLuca Teresa's most recent SEC Form 4 filing?
DeLuca Teresa's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.
What is DeLuca Teresa's total buy and sell value in the current window?
Inside the rolling retention window, DeLuca Teresa bought $305K and sold $345K based on SEC Form 4 filings.
What was DeLuca Teresa's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 21,250 SGRY shares on 2026-08-18, worth $305K, per SEC Form 4 filings.